VERBLINDUNGSKAPPE

European patent · EP4069341 · In force

Register entry

Publication number
EP4069341
Application number
EP20825163
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 27, 2020
Published
Oct 12, 2022
Granted
Jul 30, 2025
Protection ends at the latest
Nov 26, 2040
Next annual fee due
Nov 30, 2026
IPC classes
A61M 5/32 (2006.01)
A61M 5/28 (2006.01)
Priority
GB 201917728 04.12.2019
GB 202004619 30.03.2020
GB 202015182 25.09.2020
PCT application
PCT/GB2020/053029 27.11.2020
PCT publication
WO2021/111110 10.06.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 11, 2026

    Change

    Published in Swissreg on 11.06.2026

  2. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  3. Sep 1, 2025

    Agent entered

    Representative
    Kirker & Cie SA, Rue de Genève 122, CP 153, 1226 Genève-Thônex

    Published in Swissreg on 01.09.2025

  4. Jul 30, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 30.07.2025

Parties

Holder

Almac Clinical Services Limited

Almac House 20 Seagoe Industrial Estate, Craigavon County Armagh BT63 5QD, GB

Agent

Kirker & Cie SA

Rue de Genève 122 CP 153, 1226 Genève-Thônex

Inventor

CARTWRIGHT, Jonathan

Craigavon Northern Ireland BT63 5QD, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.